ProPhase Labs Inc (NASDAQ: PRPH): Can A Stock Be -56.24% Lower Year-To-Date And Still Be A Loser?

ProPhase Labs Inc (NASDAQ:PRPH)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting -0.44. At the close of trading, the stock’s price was $0.33, to imply a decrease of -2.56% or -$0.01 in intraday trading. The PRPH share’s 52-week high remains $4.84, putting it -1366.67% down since that peak but still an impressive 33.33% since price per share fell to its 52-week low of $0.22.

Analysts have given a consensus recommendation of Hold for ProPhase Labs Inc (PRPH), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give PRPH a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 0 recommend it as a Buy.

ProPhase Labs Inc (NASDAQ:PRPH) trade information

After registering a -2.56% downside in the last session, ProPhase Labs Inc (PRPH) has traded red over the past five days. The 5-day price performance for the stock is -7.46%, and -9.97% over 30 days. With these gigs, the year-to-date price performance is -56.24%.

The extremes give us $14 and $14 for target low and target high price respectively. As such, PRPH has been trading -4142.42% off suggested target high and -4142.42% from its likely low.

PRPH Dividends

ProPhase Labs Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 0.22 million shares, or about 2.3349% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.92 million.

We also have VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the ProPhase Labs Inc (PRPH) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund holds roughly 404.21 shares. This is just over 0.97% of the total shares, with a market valuation of $0.13 million. Data from the same date shows that the other fund manager holds a little less at 140.56, or 0.34% of the shares, all valued at about 46567.0.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.